Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Long-Term Investments (2020 - 2024)

Historic Long-Term Investments for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $702.3 billion.

  • Universe Pharmaceuticals' Long-Term Investments fell 142.43% to $702.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $702.3 billion, marking a year-over-year decrease of 142.43%. This contributed to the annual value of $702.3 billion for FY2025, which is 142.43% down from last year.
  • According to the latest figures from Q3 2025, Universe Pharmaceuticals' Long-Term Investments is $702.3 billion, which was down 142.43% from $712.5 billion recorded in Q3 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Long-Term Investments peaked at $712.5 billion during Q3 2024, and registered a low of $586674.0 during Q1 2022.
  • Its 5-year average for Long-Term Investments is $176.9 billion, with a median of $736489.5 in 2021.
  • Its Long-Term Investments has fluctuated over the past 5 years, first plummeted by 9999.99% in 2021, then skyrocketed by 10134487.19% in 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Long-Term Investments (Quarter) stood at $744924.0 in 2021, then dropped by 5.64% to $702890.0 in 2022, then surged by 99822.61% to $702.3 million in 2023, then skyrocketed by 101344.87% to $712.5 billion in 2024, then decreased by 1.42% to $702.3 billion in 2025.
  • Its Long-Term Investments was $702.3 billion in Q3 2025, compared to $712.5 billion in Q3 2024 and $692492.0 in Q1 2024.